×
ADVERTISEMENT

SEPTEMBER 27, 2022

Acetaminophen May Worsen Response to Immunotherapy in Cancer Patients

By Chase Doyle

Originally published by our sister publication Clinical Oncology News

Chicago—The commonly used pain reliever acetaminophen may reduce the efficacy of immunotherapy in patients with cancer, according to a new study presented at the 2022 annual meeting of the American Society of Clinical Oncology (abstract 12000).

Analysis of plasma samples from more than 600 patients with advanced cancer found that acetaminophen use was associated with significantly worse outcomes among those